You are here: Industry Insights > acquisition

News List

8 Biotechs That Could Be Taken Out Soon BioSpace.com
March 09, 2017
With the end of the 2017 first quarter on the near horizon, speculation is increasing on merger-and-acquisition activity in biopharma. StreetInsider listed eight biopharma companies it thinks are likely targets. Let’s take a look.
CROS NT Acquires PM Clinical Ltd. contractpharma
March 08, 2017
Adds regulatory consultancy, study design, feasibility, clinical project management and monitoring services
Quotient Clinical announces second US acquisition: QS Pharma pharmaasia
March 06, 2017
Quotient Clinical announced acquisition of QS Pharma, the contract development and manufacturing organisation from Charles River Laboratories International
Sartorius to Acquire Essen BioScience contractpharma
March 06, 2017
Expands bioanalytics portfolio with cell analysis platform for research and drug discovery
Quotient Clinical expands into USA through acquisition of SeaView Research, the specialist clinical pharmaasia
March 03, 2017
Acquisition combines Quotient and SeaView’s complementary customer portfolios strengthening the early phase clinical experience of the combined business.
Eli Lilly acquires CoLucid Pharmaceuticals for $960m pharmaceutical-technology
March 03, 2017
Eli Lilly and Company has completed its previously announced acquisition of US-based CoLucid Pharmaceuticals for ...
Johnson & Johnson completes acquisition of Abbott Medical Optics worldpharmanews
March 02, 2017
Johnson & Johnson (NYSE: JNJ) has completed the acquisition of Abbott Medical Optics (AMO) a wholly-owned subsidiary of Abbott.
Lilly Completes Acquisition of CoLucid Pharmaceuticals lilly
March 02, 2017
Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of CoLucid Pharmaceuticals, Inc. (NASD:CLCD).
Recipharm acquires Kemwell’s pharmaceutical businesses in India for $118.5m pharmaceutical-technology
February 22, 2017
Sweden's Recipharm has completed the previously announced acquisition of Kemwell’s pharmaceutical businesses in Bengaluru, India, in a deal valued at Skr1.05bn ($118.5m).
Takeda completes acquisition of ARIAD Pharmaceuticals biospectrumasia
February 22, 2017
This acquisition will significantly enhances Takeda’s global oncology portfolio

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page